Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Percheron Therapeutics ( (AU:PER) ) has issued an announcement.
Percheron Therapeutics Limited has scheduled a General Meeting at the request of certain shareholders under section 249D of the Corporations Act 2001. The company’s directors unanimously advise shareholders to vote against all proposed resolutions, as they do not believe these resolutions serve the best interests of the company or its shareholders.
More about Percheron Therapeutics
YTD Price Performance: -87.50%
Average Trading Volume: 4,916
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $5.45M
See more data about PER stock on TipRanks’ Stock Analysis page.
